|
DK178590D0
(da)
|
1990-07-26 |
1990-07-26 |
Novo Nordisk As |
1,4-disubstituerede piperaziner
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
DK0672031T3
(da)
|
1992-12-02 |
2003-06-10 |
Pfizer |
Catecholdiethere som selektive PDE IV-inhibitorer
|
|
DE4323192A1
(de)
|
1993-07-10 |
1995-01-12 |
Basf Ag |
Verfahren zur Herstellung von Homo- und Copolymerisaten von Alk-1-enen
|
|
DE4325846C1
(de)
|
1993-07-31 |
1995-01-19 |
Herberts Gmbh |
Verwendung von Furan-modifizierten aromatischen Pinakolderivaten als Initiatoren und Furan-modifizierte aromatische Pinakolderivate als solche
|
|
DE4343286A1
(de)
|
1993-12-17 |
1995-06-22 |
Hoechst Ag |
Heteroaromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
|
DE4409501A1
(de)
|
1994-03-19 |
1995-09-21 |
Didier Werke Ag |
Verschleißfutter eines Schachtofens und Stein hierfür
|
|
JP3056788B2
(ja)
|
1994-06-24 |
2000-06-26 |
ユーロ−セルティーク，エス．エイ． |
ホスホジエステラーゼｉｖの阻害化合物および阻害方法
|
|
US5789434A
(en)
|
1994-11-15 |
1998-08-04 |
Bayer Corporation |
Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
|
|
TW424087B
(en)
|
1995-04-06 |
2001-03-01 |
Janssen Pharmaceutica Nv |
1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives
|
|
TW332201B
(en)
|
1995-04-06 |
1998-05-21 |
Janssen Pharmaceutica Nv |
1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
|
|
US6037370A
(en)
|
1995-06-08 |
2000-03-14 |
Vertex Pharmaceuticals Incorporated |
Methods and compositions for stimulating neurite growth
|
|
EP1170009B1
(en)
|
1996-01-22 |
2004-04-07 |
Fujisawa Pharmaceutical Co., Ltd. |
Thiazolybenzofuran derivatives and their use as SRS-A and leukotiene antagonists
|
|
AU4015497A
(en)
|
1996-08-26 |
1998-03-19 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Thiazole derivatives useful as selective inhibitors of pde-iv
|
|
JPH1087543A
(ja)
|
1996-09-17 |
1998-04-07 |
Chisso Corp |
アルコキシベンゼン誘導体、液晶組成物および液晶表示素子
|
|
US6548490B1
(en)
|
1997-10-28 |
2003-04-15 |
Vivus, Inc. |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
WO1999045914A1
(en)
|
1998-03-13 |
1999-09-16 |
Maruho Kabushikikaisha |
Alkyl amine derivative and local anesthetic agent using the same
|
|
GB9807354D0
(en)
|
1998-04-07 |
1998-06-03 |
Glaxo Group Ltd |
Antiviral compound
|
|
SE9804212D0
(sv)
|
1998-12-04 |
1998-12-04 |
Astra Pharma Prod |
Compounds
|
|
TR200102817T2
(tr)
|
1999-03-12 |
2002-05-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Antiinflamatuar ajanlar olarak faydalı bileşikler
|
|
US7141593B1
(en)
|
1999-06-04 |
2006-11-28 |
Abbott Laboratories |
Pharmaceutical formulations
|
|
GB9929552D0
(en)
|
1999-12-14 |
2000-02-09 |
Proteus Molecular Design |
Compounds
|
|
JP2004511434A
(ja)
|
2000-06-15 |
2004-04-15 |
ファルマシア・コーポレーション |
インテグリン受容体アンタゴニストとしてのヘテロアリールアルカン酸
|
|
US20030032579A1
(en)
|
2001-04-20 |
2003-02-13 |
Pfizer Inc. |
Therapeutic use of selective PDE10 inhibitors
|
|
DE60209704T2
(de)
|
2001-05-22 |
2006-11-16 |
Pfizer Products Inc., Groton |
Neue kristallforme von azithromycin
|
|
AU2003229912A1
(en)
*
|
2002-04-18 |
2003-11-03 |
Avecia Limited |
Prepation of a conjugated molecule and materials for use therein
|
|
US6821502B2
(en)
|
2002-06-12 |
2004-11-23 |
Chevron U.S.A. Inc. |
Method of making aluminum-containing zeolite with IFR structure
|
|
US20050272036A1
(en)
|
2002-07-27 |
2005-12-08 |
Barton Peter J |
Ketones
|
|
AU2003275493A1
(en)
|
2002-10-08 |
2004-05-04 |
The Scripps Research Institute |
Inhibitors of fatty acid amide hydrolase
|
|
AU2003288352A1
(en)
|
2002-10-30 |
2004-06-07 |
Centre National De La Recherche Scientifique (Cnrs) |
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
|
|
TW200410921A
(en)
|
2002-11-25 |
2004-07-01 |
Hoffmann La Roche |
Mandelic acid derivatives
|
|
US20060040986A1
(en)
|
2002-12-06 |
2006-02-23 |
Kowa Co., Ltd. |
Erythropoietin production accelerator
|
|
BR0317600A
(pt)
|
2002-12-20 |
2005-11-29 |
Pharmacia Corp |
ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina
|
|
WO2004071509A1
(ja)
|
2003-02-12 |
2004-08-26 |
Nippon Chemiphar Co., Ltd. |
オリゴデンドロサイト分化促進剤
|
|
US7226930B2
(en)
|
2003-04-18 |
2007-06-05 |
Memory Pharmaceutical Corporation |
Phosphodiesterase 4 inhibitors
|
|
AR047541A1
(es)
|
2004-02-13 |
2006-01-25 |
Sandoz Ag |
Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
|
|
NZ550114A
(en)
|
2004-04-20 |
2011-02-25 |
Transtech Pharma Inc |
Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
|
|
MXPA06013250A
(es)
*
|
2004-05-14 |
2007-02-28 |
Abbott Lab |
Inhibidores de quinasa como agentes terapeuticos.
|
|
US7351833B2
(en)
|
2004-07-23 |
2008-04-01 |
Abbott Laboratories |
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
|
|
US7449486B2
(en)
*
|
2004-10-19 |
2008-11-11 |
Array Biopharma Inc. |
Mitotic kinesin inhibitors and methods of use thereof
|
|
US8436176B2
(en)
|
2004-12-30 |
2013-05-07 |
Medicis Pharmaceutical Corporation |
Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
|
|
WO2006072828A2
(en)
|
2005-01-07 |
2006-07-13 |
Pfizer Products Inc. |
Heteroaromatic quinoline compounds and their use as pde10 inhibitors
|
|
CN101384183B
(zh)
|
2005-02-04 |
2012-07-04 |
西诺米克斯公司 |
包含连接有杂芳基部分的化合物及其作为用于食物组合物的新型鲜味调节剂、促味剂和味觉增强剂的应用
|
|
US20060252807A1
(en)
|
2005-04-22 |
2006-11-09 |
Kalypsys, Inc. |
Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
MY152185A
(en)
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
|
CA2617788A1
(en)
|
2005-08-04 |
2007-02-15 |
Apogee Biotechnology Corporation |
Sphingosine kinase inhibitors and methods of their use
|
|
PT1924585E
(pt)
|
2005-08-29 |
2012-01-19 |
Sanofi Aventis Us Llc |
Nova forma cristalina de um derivado de piridazino[4,5-b]indole
|
|
DE602006019822D1
(de)
|
2005-09-13 |
2011-03-10 |
Sicor Inc |
Reines rocuroniumbromid
|
|
TWI330639B
(en)
|
2005-11-15 |
2010-09-21 |
Otsuka Pharma Co Ltd |
Oxazole compound and pharmaceutical composition
|
|
EP1968946A4
(en)
|
2005-12-23 |
2010-05-05 |
Astrazeneca Ab |
IMIDAZOLE AS MODULATORS OF THE GABA B RECEPTOR
|
|
JP2009535394A
(ja)
|
2006-05-02 |
2009-10-01 |
ファイザー・プロダクツ・インク |
Ｐｄｅ１０阻害剤としての二環式ヘテロアリール化合物
|
|
US20080090834A1
(en)
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
JP2010502736A
(ja)
|
2006-09-08 |
2010-01-28 |
オレ・ファーマシューティカルズ・インコーポレーテッド |
消化管の炎症を低減または軽減するための方法
|
|
UA99600C2
(en)
|
2006-09-25 |
2012-09-10 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
|
|
KR20090064400A
(ko)
|
2006-09-28 |
2009-06-18 |
머크 앤드 캄파니 인코포레이티드 |
Ｈｄａｃ 억제제 및 킬레이트화 가능한 금속 화합물 및 금속-ｈｄａｃ 억제제 킬레이트 착물의 약제학적 조성물
|
|
US20090253918A1
(en)
|
2006-10-02 |
2009-10-08 |
Janssen Pharmaceuticals, N.V. |
Novel intermediate for glyt1 inhibitor
|
|
US7837978B2
(en)
|
2006-10-13 |
2010-11-23 |
Chevron U.S.A. Inc. |
Process for preparing aluminum-containing molecular sieve SSZ-26
|
|
US7786139B2
(en)
|
2006-11-21 |
2010-08-31 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
EP2083819B1
(en)
|
2006-11-21 |
2017-02-22 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
PE20081506A1
(es)
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
|
WO2009008906A2
(en)
|
2007-02-06 |
2009-01-15 |
The Trustees Of The University Of Pennsylvania |
Therapeutic compounds for blocking dna synthesis of pox viruses
|
|
EP2160394A1
(en)
|
2007-05-22 |
2010-03-10 |
Ultimorphix Technologies B.v. |
Tenofovir disoproxil hemi-fumaric acid co-crystal
|
|
EP2017264A1
(de)
|
2007-07-16 |
2009-01-21 |
Bayer Cropscience Ag |
Substituierte Phenylpropargylverbindungen, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
WO2009049022A1
(en)
|
2007-10-10 |
2009-04-16 |
Ore Pharmaceuticals Inc. |
Method for treatment of pancreatitis
|
|
TW200944520A
(en)
|
2008-01-29 |
2009-11-01 |
Glaxo Group Ltd |
Spiro compounds as NPY Y5 receptor antagonists
|
|
WO2009143178A2
(en)
|
2008-05-20 |
2009-11-26 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
TWI501965B
(zh)
|
2008-06-20 |
2015-10-01 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
|
|
EP2310016B1
(en)
|
2008-08-05 |
2017-10-04 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
NZ601967A
(en)
|
2010-03-12 |
2015-03-27 |
Omeros Corp |
Pde10 inhibitors and related compositions and methods
|
|
NZ716462A
(en)
*
|
2014-04-28 |
2017-11-24 |
Omeros Corp |
Optically active pde10 inhibitor
|